The global pacemaker devices market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of cardiac diseases and rising geriatric population. The external pacemaker devices segment accounted for the largest share in the global pacemaker devices market in 2018, followed by implantable and single chamber technology segments. The implantable segment is expected to grow at a CAGR of 5% during the forecast period, from 2021 to 2030.
Some Of The Growth Factors Of This Market:
- The increasing number of cardiac surgeries and rising awareness about heart diseases are also contributing to the growth of this market in developing countries such as India and China, which have large populations with high incidence rates for cardiovascular diseases such as coronary artery disease (CAD).
- In addition, technological advancements in pacemaker devices have led to improved efficacy and safety profiles that will drive their adoption among patients with heart failure or arrhythmia conditions who require implantable cardioverter-defibrillators (ICDs) or cardiac resynchronization therapy (CRT).
Industry Growth Insights published a new data on “Pacemaker Devices Market”. The research report is titled “Pacemaker Devices Market research by Types (by Product, External, Implantable, by Technology, Single Chamber, Dual Chamber, Biventricular), By Applications (Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia), By Players/Companies Abbott Laboratories, Medtronic Plc., Oscor Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology, OSYPKA AG, Zoll Medical Corporation, Pacetronix Limited.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pacemaker Devices Market Research Report
By Type
by Product, External, Implantable, by Technology, Single Chamber, Dual Chamber, Biventricular
By Application
Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia
By Companies
Abbott Laboratories, Medtronic Plc., Oscor Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology, OSYPKA AG, Zoll Medical Corporation, Pacetronix Limited.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Pacemaker Devices Market Report Segments:
The global Pacemaker Devices market is segmented on the basis of:
Types
by Product, External, Implantable, by Technology, Single Chamber, Dual Chamber, Biventricular
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Arrhythmia, Atrial Fibrillation, Bradycardia, Tachycardia
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Medtronic Plc.
- Oscor Inc.
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Lepu Medical Technology
- OSYPKA AG
- Zoll Medical Corporation
- Pacetronix Limited.
Highlights of The Pacemaker Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- by Product
- External
- Implantable
- by Technology
- Single Chamber
- Dual Chamber
- Biventricular
- By Application:
- Arrhythmia
- Atrial Fibrillation
- Bradycardia
- Tachycardia
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pacemaker Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pacemaker devices are medical implants that help to regulate the heart rate. They can be used to treat conditions such as atrial fibrillation (AF), a common condition in which the heart beats too fast and can cause problems with blood flow.
Some of the major companies in the pacemaker devices market are Abbott Laboratories, Medtronic Plc., Oscor Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology, OSYPKA AG, Zoll Medical Corporation, Pacetronix Limited..
The pacemaker devices market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pacemaker Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pacemaker Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pacemaker Devices Market - Supply Chain
4.5. Global Pacemaker Devices Market Forecast
4.5.1. Pacemaker Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pacemaker Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pacemaker Devices Market Absolute $ Opportunity
5. Global Pacemaker Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pacemaker Devices Market Size and Volume Forecast by Type
5.3.1. by Product
5.3.2. External
5.3.3. Implantable
5.3.4. by Technology
5.3.5. Single Chamber
5.3.6. Dual Chamber
5.3.7. Biventricular
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pacemaker Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pacemaker Devices Market Size and Volume Forecast by Application
6.3.1. Arrhythmia
6.3.2. Atrial Fibrillation
6.3.3. Bradycardia
6.3.4. Tachycardia
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pacemaker Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pacemaker Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pacemaker Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pacemaker Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pacemaker Devices Demand Share Forecast, 2019-2029
9. North America Pacemaker Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pacemaker Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pacemaker Devices Market Size and Volume Forecast by Application
9.4.1. Arrhythmia
9.4.2. Atrial Fibrillation
9.4.3. Bradycardia
9.4.4. Tachycardia
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pacemaker Devices Market Size and Volume Forecast by Type
9.7.1. by Product
9.7.2. External
9.7.3. Implantable
9.7.4. by Technology
9.7.5. Single Chamber
9.7.6. Dual Chamber
9.7.7. Biventricular
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pacemaker Devices Demand Share Forecast, 2019-2029
10. Latin America Pacemaker Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pacemaker Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pacemaker Devices Market Size and Volume Forecast by Application
10.4.1. Arrhythmia
10.4.2. Atrial Fibrillation
10.4.3. Bradycardia
10.4.4. Tachycardia
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pacemaker Devices Market Size and Volume Forecast by Type
10.7.1. by Product
10.7.2. External
10.7.3. Implantable
10.7.4. by Technology
10.7.5. Single Chamber
10.7.6. Dual Chamber
10.7.7. Biventricular
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pacemaker Devices Demand Share Forecast, 2019-2029
11. Europe Pacemaker Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pacemaker Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pacemaker Devices Market Size and Volume Forecast by Application
11.4.1. Arrhythmia
11.4.2. Atrial Fibrillation
11.4.3. Bradycardia
11.4.4. Tachycardia
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pacemaker Devices Market Size and Volume Forecast by Type
11.7.1. by Product
11.7.2. External
11.7.3. Implantable
11.7.4. by Technology
11.7.5. Single Chamber
11.7.6. Dual Chamber
11.7.7. Biventricular
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pacemaker Devices Demand Share, 2019-2029
12. Asia Pacific Pacemaker Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pacemaker Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pacemaker Devices Market Size and Volume Forecast by Application
12.4.1. Arrhythmia
12.4.2. Atrial Fibrillation
12.4.3. Bradycardia
12.4.4. Tachycardia
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pacemaker Devices Market Size and Volume Forecast by Type
12.7.1. by Product
12.7.2. External
12.7.3. Implantable
12.7.4. by Technology
12.7.5. Single Chamber
12.7.6. Dual Chamber
12.7.7. Biventricular
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pacemaker Devices Demand Share, 2019-2029
13. Middle East & Africa Pacemaker Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pacemaker Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pacemaker Devices Market Size and Volume Forecast by Application
13.4.1. Arrhythmia
13.4.2. Atrial Fibrillation
13.4.3. Bradycardia
13.4.4. Tachycardia
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pacemaker Devices Market Size and Volume Forecast by Type
13.7.1. by Product
13.7.2. External
13.7.3. Implantable
13.7.4. by Technology
13.7.5. Single Chamber
13.7.6. Dual Chamber
13.7.7. Biventricular
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pacemaker Devices Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Pacemaker Devices Market: Market Share Analysis
14.2. Pacemaker Devices Distributors and Customers
14.3. Pacemaker Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic Plc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Oscor Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biotronik SE & Co. KG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lepu Medical Technology
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. OSYPKA AG
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Zoll Medical Corporation
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Pacetronix Limited.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
